Abstract:Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 has become disaster for human society. As the pandemic becomes more regular, we should develop more rapid and accurate detection methods to achieve early diagnosis and treatment. Antigen detection methods based on spike protein has great potential, however, it has not been effectively developed, probably due to the torturing conformational complexity. By utilizing cross-blocking data, we clustered SARS-CoV-2 receptor binding domain (RBD)-specific monoclonal antibodies (mAbs) into 6 clusters. Subsequently, the antigenic sites for representative mAbs were identified by RBDs with designed residue substitutions. The sensitivity and specificity of selected antibody pairs was demonstrated using serial diluted samples of SARS-CoV-2 S protein and SARS-CoV S protein. Furthermore, pseudovirus system was constructed to determine the detection capability against SARS-CoV-2 and SARS-CoV. 6 RBD-specific mAbs, recognizing different antigenic sites, were identified as potential candidates for optimal antibody pairs for detection of SARS-CoV-2 S protein. By considering relative spatial position, accessibility and conservation of corresponding antigenic sites, affinity and the presence of competitive antibodies in clinical samples, 6H7-6G3 was rationally identified as optimal antibody pair for detection of both SARS-CoV-2 and SARS-CoV. Furthermore, our results showed that 6H7 and 6G3 effectively bind to SARS-CoV-2 variants of concern (VOCs). Taken together, we identified 6H7-6G3 antibody pair as a promising rapid antigen diagnostic tool in containing COVID-19 pandemic caused by multiple VOCs. Moreover, our results also provide an important reference in screening of antibody pairs detecting antigens with complex conformation.

Diverse SARS-CoV-2 Aptamers Overcome Variant Antigenic Shift.

Broadly SARS-CoV-2 aptamers overcome variant antigenic shift

Aptamers Targeting SARS-COV-2: a Promising Tool to Fight Against COVID-19.

Fighting Mutations with Mutations: Evolutionarily Adapting a DNA Aptamer for High-Affinity Recognition of Mutated Spike Proteins of SARS-CoV-2

Aptamer‐based Strategies Against SARS‐CoV‐2 Viruses

Broadly neutralizing aptamers to SARS-CoV-2: a diverse panel of modified DNA antiviral agents

Parallel profiling of antigenicity alteration and immune escape of SARS-CoV-2 Omicron and other variants

Comprehensive Overview of Broadly Neutralizing Antibodies against SARS-CoV-2 Variants

Aptamer‐ased Strategies Against SARS‐CoV‐2 Viruses (3/2023)

Aptamers targeting SARS-CoV-2 nucleocapsid protein exhibit potential anti pan-coronavirus activity

Nucleocapsid protein binding DNA aptamers for detection of SARS-COV-2

Optimizing a Human Monoclonal Antibody for Better Neutralization of SARS-CoV-2

Potential of Antibody Pair Targeting Conserved Antigenic Sites in Diagnosis of SARS-CoV-2 Variants Infection

A Broadly Neutralizing Antibody Inhibits SARS-CoV-2 Variants Through a Novel Mechanism of Disrupting Spike Trimer Integrity

Monoclonal antibodies against S2 subunit of spike protein exhibit broad reactivity toward SARS-CoV-2 variants

In-Silico Selection of Aptamer Targeting SARS-CoV-2 Spike Protein

Two antibodies show broad, synergistic neutralization against SARS-CoV-2 variants by inducing conformational change within the RBD

Novel Monoclonal Antibodies and Recombined Antibodies Against Variant SARS-CoV-2

Antibodies with Potent and Broad Neutralizing Activity Against Antigenically Diverse and Highly Transmissible SARS-CoV-2 Variants

Discovery of Aptamers Targeting the Receptor-Binding Domain of the SARS-CoV-2 Spike Glycoprotein

Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants